copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Biogen CEO sees no burning need for more acquisitions "The view out there in the analyst community is that the future of Biogen depends on the next deal that we do and that's not a view that we share inside Biogen," CEO Chris Viehbacher told
Christopher A. Viehbacher, CEO of Biogen Christopher A Viehbacher has been the CEO of Biogen since November 2022, stepping in at a critical time for the company With a strong background in healthcare, having previously served as Global CEO of Sanofi, he knows the industry well
Biogen CEO Up Against Revenue Decline After Alzheimer’s Bottlenecks and . . . Biogen CEO Christopher Viehbacher has made some tricky moves since he took charge three years ago The former Sanofi CEO has aimed to adjust the biotech’s priorities and spending to reflect failing areas and promising new drugs coming up for launch
Biogen CEO Christopher Viehbacher at LABEST At LABEST 2024, Belldegrun introduced keynote speaker Christopher Viehbacher, the current President and CEO of Biogen, with equal parts admiration, personal reflection, and deep understanding of the stakes in modern medicine
New Biogen CEO seeks to ‘redefine’ company after challenging year New Biogen CEO seeks to ‘redefine’ company after challenging year Christopher Viehbacher, who took over as head of the biotech late last year, aims to better balance Biogen’s high-risk, high-reward drug pipeline, but said he’d avoid making “radical left turns ”